Human papillomavirus risk perceptions and relationship status: a barrier to HPV vaccination?

Thompson, Erika L.; Vamos, Cheryl A.; Piepenbrink, Rumour; Kadono, Mika; Vázquez-Otero, Coralia; Matthes, Sarah; Daley, Ellen M.

doi:10.1007/s10865-019-00025-4

Cited by 18 publications

(11 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Echoing findings from previous research (Thompson, Vamos, Straub, Sappenfield, & Daley, 2017;Thompson, Vamos, et al, 2019b;Waters, Merrell, & Thompson, 2021), being monogamously coupled led many women to perceive themselves as low risk for new HPV infections. Coupled with a) commonly held false beliefs that safer sex practices, such as condom use, provide sufficient protection against HPV and b) low awareness that HPV vaccination can protect against new HPV infections after sexual debut, low perceived benefit may also discourage shared clinical decision-making and vaccine acceptance for some 27-to 45year-old women.…”

Section: Discussionmentioning

confidence: 94%

“I Thought It Was Just For Teenagers”: Knowledge, Attitudes, and Beliefs about HPV Vaccination Among Women Aged 27 to 45

Polonijo

Mahapatra

Brown

2022

Women's Health Issues

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 94%

“I Thought It Was Just For Teenagers”: Knowledge, Attitudes, and Beliefs about HPV Vaccination Among Women Aged 27 to 45

Polonijo

Mahapatra

Brown

2022

Women's Health Issues

View full text Add to dashboard Cite

“…4 Among young adults ages 18-26, 46% of women and 15% of men ages 18-26 reported previous HPV vaccination. 5 While national estimates of adolescent and young adults uptake of the HPV vaccine are obtained through surveys such as the National Immunization Survey-Teen (NIS-Teen) and the National Health Interview Survey, 4 less is known about the current rates of HPV vaccination among adults older than age 26. Assessment of adult HPV vaccination coverage may be of particular importance as on-time vaccination of 11-12-year-old adolescents requires parental acceptance of the HPV vaccine.…”

Section: Introductionmentioning

confidence: 99%

Associations between HPV vaccination among women and their 11–14-year-old children

Kornides

Head

Feemster

et al. 2019

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

The human papillomavirus (HPV) vaccine has been available in the United States for over a decade. We sought to examine the associations between self-reported receipt of HPV vaccination among women and their 11-14-year-old children in 27 low-coverage states. Among the 3,261 mothers we surveyed, 18% reported receiving ≥1 dose of HPV vaccine. A significantly higher proportion of vaccinated women reported vaccination of their children compared to unvaccinated women (83% vs. 56%, p < .001). In multivariable logistic regression, vaccinated women (vs. unvaccinated) had 3.58 (95% CI: 2.81-4.56) times the adjusted-odds of vaccinating their children (≥1 dose HPV vaccine). Among unvaccinated children, vaccinated mothers (vs. unvaccinated) had 3.32 (95% CI: 2.09-5.26) times the adjusted odds of high intention to vaccinate their children in the next 12 months. We did not observe associations between mothers' vaccination confidence and their vaccination status. We conclude that mothers who received ≥1 dose of HPV vaccine may be more likely to initiate or highly intend to initiate the HPV vaccine series for their children. This may have important implications for meeting population goals for HPV vaccination coverage as an increasing proportion of mothers are likely to be vaccinated over time.

show abstract

“…Ensure vaccine safety is addressed in social mobilization events, and that caregivers know how to report AEFIs Humanitarian emergencies and outbreak settings • Unknown or incomplete immunization history of the affected population • Population may not have been socialized to vaccination benefits • Context can deprioritize immunization over more pressing health, security, and livelihood concerns• Use existing community leadership structures to build confidence and trust in vaccines among45 …”

mentioning

confidence: 99%

Mobilize to vaccinate: lessons learned from social mobilization for immunization in low and middle-income countries

Jalloh

Wilhelm

Abad

et al. 2019

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Creating and sustaining demand for immunization services is a global priority to ensure that vaccineeligible populations are fully protected from vaccine-preventable diseases. Social mobilization remains a key health promotion strategy used by low-and middle-income countries (LMICs) to promote vaccination demand. In this commentary, we synthesize illustrative evidence on successful social mobilization efforts promoting the uptake of immunization services in select LMICs. The first example focuses on Sierra Leone's routine immunization program during the Universal Child Immunization initiative in the late 1980s. We then give an example of India's establishment of a social mobilization network in the early-to mid-2000s to support polio elimination in high-risk communities. Thirdly, we highlight the complexities of social mobilization in a humanitarian emergency during the 2017-2018 diphtheria outbreak among displaced Rohingyas in camps and settlements in Bangladesh. Lastly, we draw upon examples from the introduction of the human papillomavirus vaccine in several countries. We then critically examine recurring challenges faced when implementing social mobilization for immunization in LMICs and offer practical recommendations for improvement.

show abstract

Human papillomavirus risk perceptions and relationship status: a barrier to HPV vaccination?

Cited by 18 publications

References 31 publications

“I Thought It Was Just For Teenagers”: Knowledge, Attitudes, and Beliefs about HPV Vaccination Among Women Aged 27 to 45

“I Thought It Was Just For Teenagers”: Knowledge, Attitudes, and Beliefs about HPV Vaccination Among Women Aged 27 to 45

Associations between HPV vaccination among women and their 11–14-year-old children

Mobilize to vaccinate: lessons learned from social mobilization for immunization in low and middle-income countries

Contact Info

Product

Resources

About